Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 4 2Phase 3 2

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Anorexia 6Cachexia 5Weight Loss 3Breast Neoplasms 3Neoplasms 2Lung Neoplasms 2Body Weight 2Squamous Cell Carcinoma of Head and Neck 1Prosthesis Failure 1Pancreatic Neoplasms 1Nutrition Disorders 1Menorrhagia 1Liver Neoplasms 1Leiomyoma 1Hot Flashes 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Esthesioneuroblastoma, Olfactory 1Endometrial Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Body Weight Changes 1

Interventions

Paclitaxel 20Gemcitabine 16Dexamethasone 16Bevacizumab 16Docetaxel 15Oxaliplatin 14Cyclophosphamide 13Carboplatin 12Capecitabine 12Sorafenib 11Fluorouracil 11Leucovorin 10Cisplatin 10pembrolizumab 9Prednisone 9Pemetrexed 9Epoetin Alfa 9venetoclax 8atezolizumab 8Fentanyl 8Drug Therapy 8Doxorubicin 8Rivaroxaban 7Rituximab 7Darbepoetin alfa 7Anastrozole 7Panitumumab 6Ondansetron 6Morphine 6Irinotecan 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Neoplasms × Megestrol Acetate × Clear all
NCT06500234 2024-07-15

Nutrition Impact on Immunotherapy of Cancer

Qingdao Central Hospital

Phase 3 Recruiting
300 enrolled

Neoplasms, Nutrition Disorders, Prosthesis Failure

NCT00637806 2016-05-02

Treatment of Cancer-associated Anorexia Using Megestrol Acetate Concentrated Suspension

Par Pharmaceutical, Inc.

Phase 3 Terminated
4 enrolled 6 charts

Anorexia, Body Weight, Cachexia, Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡